Oncology
General Information
The Department of Pharmacy at The Johns Hopkins Hospital offers an ASHP accredited Specialized Residency in Oncology Pharmacy Practice. This one- year program is designed to provide advanced training in clinical oncology pharmacy practice focusing on patient care, clinical research and education.
Benefits
> Find out about general benefits
Program Fundamentals
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is one of only 39 cancer centers in the United States designated by the National Cancer Institute (NCI) as a comprehensive cancer center. With the exception of the pediatric population, oncology patients seen at the Cancer Center receive the majority of their care in the Weinberg Building. The Weinberg Building contains 62 beds dedicated to the Medical Oncology, Hematology and Bone Marrow Transplantation services. Also contained within the Weinberg Building are 16 operating suites, 72 surgical beds, 20 intensive and intermediate care beds, an oncology outpatient clinic, and an outpatient treatment center.
Pharmaceutical care for the oncology patients in the Weinberg Building is provided through a pharmacy satellite located within the facility that operates 24 hours a day. Members of the pharmacy staff participate in daily multidisciplinary patient care rounds, therapeutic drug monitoring, nutrition support, providing drug information, in-service education, continuing education and patient education. Examples of multidisciplinary conferences that the staff and the residents have the opportunity to attend include Oncology Grand Rounds, Oncology Journal Club, Oncology Pain Conference and disease-specific case conferences.
The Oncology Pharmacy Practice Residency is a twelve-month program. Currently, ten months are devoted to orientation and core experiences. Two months are available for electives. Core experiences include medical oncology, hematology, bone marrow transplantation, radiation oncology, gynecological oncology, investigational drugs, outpatient treatment center, pain management and pediatric oncology. Residents will spend one afternoon each week in the outpatient treatment center or in the oncology outpatient clinic as part of a longitudinal experience. Some examples of elective experiences available to the residents include oncology clinical pharmacokinetics, immunocompromised infectious diseases, drug information, and oncology pharmacy administration. Residents may pursue elective opportunities at outside institutions, if desired.
There are many opportunities for the oncology residents to involve themselves in teaching throughout the residency year. The Kimmel Cancer Center is a training site for medical students and residents, as well as oncology fellows. Pharmacy students and pharmacy practice residents frequently complete oncology rotations in the Kimmel Cancer Center. The University of Maryland School of Pharmacy, also located in Baltimore, provides opportunities for didactic and experiential teaching.
Over the course of the year, the resident will gain experience in the management of various solid and hematologic malignancies. Since, the Kimmel Cancer Center is active in clinical research, the resident will become familiar with investigational cancer treatments, as well as the standard of care. The resident will become comfortable recognizing and managing cancer- and treatment-related complications, such as pain, infection, alterations in fluids/electrolytes/nutrition, hematologic toxicities and gastrointestinal toxicities. Upon completion of the residency, the resident will have developed the clinical skills necessary to practice as an oncology clinical specialist.
Application Process
Candidates interested in the program should submit a letter of interest explaining career objectives, a curriculum vitae, three letters of recommendation, and an academic transcript. Additionally, candidates must have a Doctor of Pharmacy degree from an accredited program and a Pharmacy Practice (PGY1) Residency. The resident is required to be licensed pharmacist in the state of Maryland.
Application Deadline: January 2
| Program Director Amy J. Hatfield, Pharm.D., BCOP Title: Clinical Specialist, Hematologic Malignancies Education: Doctor of Pharmacy, University of North Carolina at Chapel Hill Training: Pharmacy Practice Residency – University of Washington Medical Center Oncology Specialty Residency – University of Washington Medical Center/Seattle Cancer Care Alliance Practice Area: Hematologic Malignancies Research Interests: Hematologic toxicities/support, immunocompromised infectious diseases, oncologic emergencies |
Contact Information
Amy J. Hatfield, Pharm.D., BCOP
Program Director, Oncology Pharmacy Practice Residency
Department of Pharmacy
The Johns Hopkins Hospital
600 North Wolfe Street / Carnegie 180
Baltimore, Maryland 21287-6180
Phone: (443) 287-5194
Email: ahatfie2 @jhmi.edu
